SurModics, Inc. (NASDAQ:SRDX)

CAPS Rating: 2 out of 5

Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.

Recs

0
Player Avatar morgnlll (< 20) Submitted: 12/9/2006 9:19:04 PM : Outperform Start Price: $33.13 SRDX Score: -55.59

Will win out in the coated stent race.

Report this Post Reply

Featured Broker Partners


Advertisement